Experiment: 8DPX

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N TROSY-HSQC	400 uM [U-100% 15N, U-100% 13C, U-85% 2H] DR5 ectodomain, 4.4 mM DGS-NTA (Ni), 44 mM DMPC, 88 mM D7PC	95% H2O/5% D2O	50 mM	7.2	1 atm	310
2	3D HNCA	400 uM [U-100% 15N, U-100% 13C, U-85% 2H] DR5 ectodomain, 4.4 mM DGS-NTA (Ni), 44 mM DMPC, 88 mM D7PC	95% H2O/5% D2O	50 mM	7.2	1 atm	310
3	3D HN(CO)CA	400 uM [U-100% 15N, U-100% 13C, U-85% 2H] DR5 ectodomain, 4.4 mM DGS-NTA (Ni), 44 mM DMPC, 88 mM D7PC	95% H2O/5% D2O	50 mM	7.2	1 atm	310
4	3D HN(CA)CO	400 uM [U-100% 15N, U-100% 13C, U-85% 2H] DR5 ectodomain, 4.4 mM DGS-NTA (Ni), 44 mM DMPC, 88 mM D7PC	95% H2O/5% D2O	50 mM	7.2	1 atm	310
5	3D HNCO	400 uM [U-100% 15N, U-100% 13C, U-85% 2H] DR5 ectodomain, 4.4 mM DGS-NTA (Ni), 44 mM DMPC, 88 mM D7PC	95% H2O/5% D2O	50 mM	7.2	1 atm	310
6	3D HNCACB	400 uM [U-100% 15N, U-100% 13C, U-85% 2H] DR5 ectodomain, 4.4 mM DGS-NTA (Ni), 44 mM DMPC, 88 mM D7PC	95% H2O/5% D2O	50 mM	7.2	1 atm	310
8	3D HN(COCA)CB	400 uM [U-100% 15N, U-100% 13C, U-85% 2H] DR5 ectodomain, 4.4 mM DGS-NTA (Ni), 44 mM DMPC, 88 mM D7PC	95% H2O/5% D2O	50 mM	7.2	1 atm	310
7	3D 1H-15N NOESY-TROSY	500 uM [U-100% 15N; U-100% 2H] DR5 ectodomain, 5.5 mM DGS-NTA (Ni), 55 mM DMPC, 110 mM D7PC	95% H2O/5% D2O	50 mM	7.2	1 atm	310
9	3D 1H-15N NOESY-TROSY	500 uM [U-100% 15N; U-100% 2H] DR5 ectodomain, 5.5 mM DGS-NTA (Ni), 55 mM DMPC, 110 mM D7PC	95% H2O/5% D2O	50 mM	7.2	1 atm	310
10	3D 1H-15N NOESY-TROSY	250 uM [U-100% 15N; U-100% 2H] Isotopically mixed DR5 ectodomain, 250 uM [U-100% 13C] DR5 ectodomain, 5.5 mM DGS-NTA (Ni), 55 mM DMPC, 110 mM D7PC	95% H2O/5% D2O	50 mM	7.2	1 atm	310
11	13C-filtered 1H-15N NOESY-TROSY	250 uM [U-100% 13C; U-100% 15N; U-95% 2H] Isotopically mixed DR5 ectodomain, 250 uM DR5 ectodomain, 5.5 mM DGS-NTA (Ni), 55 mM DMPC, 110 mM D7PC	95% H2O/5% D2O	50 mM	7.2	1 atm	310
12	2D 1H-13C HSQC	250 uM [U-100% 15N; U-100% 2H] Isotopically mixed DR5 ectodomain, 250 uM [U-100% 13C] DR5 ectodomain, 5.5 mM DGS-NTA (Ni), 55 mM DMPC, 110 mM D7PC	95% H2O/5% D2O	50 mM	7.2	1 atm	310
13	3D 1H-15N NOESY-TROSY	500 uM [U-100% 13C; U-100% 15N] DR5 ectodomain, 5.5 mM DGS-NTA (Ni), 55 mM DMPC, 110 mM D7PC	95% H2O/5% D2O	50 mM	7.2	1 atm	310
14	3D 1H-13C NOESY aliphatic	500 uM [U-100% 13C; U-100% 15N] DR5 ectodomain, 5.5 mM DGS-NTA (Ni), 55 mM DMPC, 110 mM D7PC	95% H2O/5% D2O	50 mM	7.2	1 atm	310
15	2D 1H-15N TROSY-HSQC	400 uM [U-100% 15N, U-85% 2H] DR5 ectodomain, 4.4 mM DGS-NTA (Ni), 44 mM DMPC, 88 mM D7PC	95% H2O/5% D2O	50 mM	7.2	1 atm	310

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600
2	Bruker	AVANCE NEO	700
3	Bruker	AVANCE	800

NMR Refinement
Method	Details	Software
simulated annealing		X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	15
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	data analysis	XEASY		Bartels et al.
3	data analysis	CcpNmr Analysis	Version 2	Vranken et al
4	data analysis	TALOS+		Shen
5	refinement	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.